Minivelle 0.075 MG/Day Twice Weekly Transdermal System
- RxCUI
- 1357007
- RxNorm name
- Minivelle 0.075 MG/Day Twice Weekly Transdermal System
- Display name
- Minivelle 0.075 MG/Day Twice Weekly Transdermal System
- Full name
- Minivelle 0.075 MG/Day Twice Weekly Transdermal System
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6c5c47ab-28ee-11e1-bfc2-0800200c9a66 | Minivelle 0.075 MG/Day Twice Weekly Transdermal System [PSN] · 84 HR estradiol 0.00313 MG/HR Transdermal System [Minivelle] [SBD] · 84 HR Minivelle 0.00313 MG/HR Transdermal System [SY] · Minivelle 0.075 MG per 24HR Twice Weekly Transdermal Patch [SY] · Minivelle 0.075 MG/Day Twice Weekly Transdermal System [SY] | 5 | 19 | These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 1975 | 20240222 |